Episode Details

Back to Episodes

Trump's New Drug Tariffs: Boosting US Production

Published 13 hours ago
Description

President Trumps executive order imposes 100% tariffs on certain pharmaceutical products, aiming to boost domestic drug production. Companies can reduce tariffs by shifting manufacturing to the US and securing pricing agreements with Health and Human Services. Big pharma gets a 120-day grace period. The move targets overpriced drugs compared to Europe and Japan, potentially creating jobs and factories. Trade partners like Switzerland, Japan, South Korea, and the EU face 15% tariffs.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/b0dd0022f0cc3340

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us